An independent two-stage DCF analysis by a frontier AI model.
" data-astro-cid-2cjgdixa> CME Group continues to maintain high FCF generation. Revenue has shown resilient single-digit to low-double-digit growth, but operational leverage is exceptional. A 10% cash flow expansion reasonably balances consistent volume growth and their incredibly robust margin profile.
" data-astro-cid-2cjgdixa> CME Group continues to maintain high FCF generation. Revenue has shown resilient single-digit to low-double-digit growth, but operational leverage is exceptional. A 10% cash flow expansion reasonably balances consistent volume growth and their incredibly robust margin profile.
" data-astro-cid-2cjgdixa> CME Group continues to maintain high FCF generation. Revenue has shown resilient single-digit to low-double-digit growth, but operational leverage is exceptional. A 10% cash flow expansion reasonably balances consistent volume growth and their incredibly robust margin profile.
Intrinsic value per share under varying discount rate and terminal growth rate assumptions.
| WACC ↓ / Terminal → | 7.0% | 7.5% | 8.0% | 8.5% | 9.0% |
|---|---|---|---|---|---|
| 7.0% | $6.50 | $6.50 | $6.50 | $6.50 | $6.50 |
| 7.5% | $6.50 | $6.50 | $6.50 | $6.50 | $6.50 |
| 8.0% | $6.50 | $6.50 | $6.50 | $6.50 | $6.50 |
| 8.5% | $6.50 | $6.50 | $6.50 | $6.50 | $6.50 |
| 9.0% | $6.50 | $6.50 | $6.50 | $6.50 | $6.50 |
■ Undervalued vs current price ■ Overvalued vs current price
Westmount Research. "CME Group Inc. (CME) Intrinsic Value: A DCF Analysis." westmountfundamentals.com, March 18, 2026.
Disclaimer: The numbers presented on this page are for educational and entertainment purposes only. They are the result of a deterministic mathematical model fed with assumptions generated by an Artificial Intelligence (Gemini 3.1). This does not constitute investment advice. Always conduct your own due diligence before investing in the stock market.